In this forward-looking EyePod episode, glaucoma expert Joel S. Schuman, MD, FACS, joins Sheryl Stevenson to examine the technologies poised to influence clinical decision-making in the coming year. The discussion moves beyond innovation headlines to critically evaluate tools approaching real-world adoption—from artificial intelligence–driven imaging analytics and multimodal risk prediction models to remote monitoring platforms and sustained intraocular drug delivery systems.
Dr. Schuman explores how AI is evolving from research validation to regulatory acceptance, with applications in OCT progression analysis, visual field interpretation, and integration of imaging with electronic health record data. The episode also reviews the expanding role of home-based diagnostics, including tonometry and virtual reality–enabled perimetry, highlighting both their promise in early detection and the…
